Evidence map›Paper›PMID 30477476›Full record

ArticleBMC medical imaging2018

Prognostic value of metabolic tumor volume of pretreatment

Soma Kumasaka, Takahito Nakajima, Yukiko Arisaka, Azusa Tokue, Arifudin Achmad, Yasuhiro Fukushima, Kimihiro Shimizu, Kyoichi Kaira, Tetsuya Higuchi, Yoshito Tsushima

Open access · goldAbstract read
In one paragraph

Article in BMC medical imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. L-3-[International journal of molecular sciences · 2025
    Pooled it
  2. CD98 Light Chain LAT1 Tracers in PET-CT Diagnosis of Cancer Patients.Anti-cancer agents in medicinal chemistry · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Soma KumasakaDepartment of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Showa-machi 3-39-22, Maebashi, Gunma, 371-8511, Japan. kumasaka88@gmail.com.ORCID 0000-0001-5541-3847
Takahito NakajimaDepartment of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Showa-machi 3-39-22, Maebashi, Gunma, 371-8511, Japan.
Yukiko ArisakaDepartment of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Showa-machi 3-39-22, Maebashi, Gunma, 371-8511, Japan.
Azusa TokueDepartment of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Showa-machi 3-39-22, Maebashi, Gunma, 371-8511, Japan.
Arifudin AchmadDepartment of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Showa-machi 3-39-22, Maebashi, Gunma, 371-8511, Japan.
Yasuhiro FukushimaCurrent affiliation is Division of Clinical Radiology Service, Kyoto University Hospital, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
Kimihiro ShimizuDepartment of Thoracic and Visceral Organ Surgery, Gunma University Graduate School of Medicine, Showa-machi 3-39-22, Maebashi, Gunma, 371-8511, Japan.
Kyoichi KairaDepartment of Oncology Clinical Development, Gunma University Graduate School of Medicine, Showa-machi 3-39-22, Maebashi, Gunma, 371-8511, Japan.
Tetsuya HiguchiDepartment of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Showa-machi 3-39-22, Maebashi, Gunma, 371-8511, Japan.
Yoshito TsushimaDepartment of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Showa-machi 3-39-22, Maebashi, Gunma, 371-8511, Japan.
Gunma University · JPKyoto University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to determine the prognostic value of positron emission tomography (PET) metabolic parameters-namely metabolic tumor volume (MTV), total lesion glycolysis (TLG), and total lesion retention (TLR)-on fluorine-18 (

methodsThe study group comprised 112 NSCLC patients who underwent

resultsHigher TNM, higher clinical stage, inoperable status, and higher values for all PET parameters (both

conclusionsMTV of

Indexed as

AdultAgedAged, 80 and overalpha-MethyltyrosineCarcinoma, Non-Small-Cell LungFemaleFluorine RadioisotopesHumansLung NeoplasmsMaleMiddle AgedNeoplasm StagingPositron Emission Tomography Computed TomographyPrognosisRetrospective StudiesSensitivity and Specificityalpha-MethyltyrosineFluorine-18Fluorine Radioisotopes18F-FAMT PET/CTLung cancerMetabolic tumor volumePETPrognosis

Identifiers

PMID30477476
PMCPMC6258278
OpenAlexW2902610650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.